Advertisement

Bob Ward, President and CEO of DSM PTG, talks about a joint development project his company is working on to develop an affinity therapy device that has applications with infectious and inflammatory diseases.

Visit http://www.dsm.com to find out more about DSM PTG.

Advertisement
Advertisement